SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-058297
Filing Date
2014-09-16
Accepted
2014-09-16 19:33:27
Documents
2
Period of Report
2014-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3307
2 EX-24 DOCUMENT attachment1.htm EX-24 4330
  Complete submission text file 0001209191-14-058297.txt   9021
Mailing Address 1 Broadway 14TH FLOOR Cambridge MA 02142
Business Address 1 Broadway 14TH FLOOR Cambridge MA 02142 617-225-4348
Tokai Pharmaceuticals Inc (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AILERON THERAPEUTICS INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Yanchik Joseph A., III (Reporting) CIK: 0001618154 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 141106560